Skip to main content
. 2020 Nov 1;27(11):1183–1207. doi: 10.5551/jat.54353

Supplemental Table 8. Distribution of LDL particle sizes (absolute values).

Baseline Week 12
Cholesterol particle size of LDL, nm
    Placebo 25.94 (25.61, 26.25) 25.92 (25.60, 26.25)
    Evolocumab 25.94 (25.71, 26.24) 26.12 (25.81, 26.44)

Change from baseline, %
    Placebo 0.00 (−0.81, 0.78)
    Evolocumab 0.39 (−0.42, 1.24)

Abbreviation: LDL, low-density lipoprotein. Data are expressed as median (1st quartile, 3rd quartile).